Pricing Log in Create free account

NKGen Biotech, Inc. (NKGN) vs VistaGen Therapeutics, Inc. (VTGN)

NKGen Biotech, Inc. and VistaGen Therapeutics, Inc. are both Biotechnology companies. NKGen Biotech, Inc. and VistaGen Therapeutics, Inc. are of similar size ($9.5M and $8.8M). NKGen Biotech, Inc. has the higher net margin (0.00% vs −2,703.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, NKGen Biotech, Inc. leads on 7 and VistaGen Therapeutics, Inc. on 4.

Valuation

Metric NKGN VTGN Biotechnology median
P/E n/m n/m 8.50
P/S n/m 3.44 9.71
P/B n/m 0.35 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.21 0.64
EV/Sales n/m (5.93) 9.21
Earnings yield (10,600.00%) (830.00%) (33.15%)
Free cash flow yield (4,296.38%) (726.47%) (25.50%)

Profitability

Metric NKGN VTGN Biotechnology median
Gross margin — 100.00% 65.16%
Operating margin 0.00% (2,785.69%) 0.00%
Net margin 0.00% (2,703.72%) 0.00%
Free cash flow margin 0.00% (2,490.88%) 0.00%
Return on equity 44.70% (166.46%) (56.36%)
Return on assets (146.49%) (129.22%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric NKGN VTGN Biotechnology median
Revenue growth (TTM) — 287.15% 6.02%
EPS growth (last fiscal year) 71.38% (9.58%) 30.26%
Revenue growth, 5-year CAGR — 3.10% 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric NKGN VTGN Biotechnology median
Debt to equity (0.59) 0.00 0.00
Current ratio 0.05 3.07 4.72
Net debt to EBITDA (1.69) 0.63 0.96

Dividend

Metric NKGN VTGN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric NKGN VTGN Biotechnology median
Market cap 8.76m 9.45m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack